Allison Upalawanna

Allison Upalawanna serves as the Vice President and Global Head of Clinical Operations & Strategy at Schrödinger since May 2023. Prior to this role, Allison was the Vice President and Global Head of Clinical Operations at Innovent Biologics from October 2021 to April 2023. A notable tenure at Novartis from June 2011 to October 2021 included positions such as Head of Strategy & Operations for Clinical Operations in Oncology Medical Affairs and Global Trial Director for Strategic Transformation in Global Drug Development. Additional experience encompasses roles at Rutgers University as Adjunct Faculty, Walgreens as a pharmacist, PPD in project management for ophthalmology, and Gentris Corporation as an Associate Scientist in pharmacogenomics. Education includes a Doctor of Pharmacy (Pharm.D.) from the University of North Carolina at Chapel Hill and a B.S. in Biochemistry with a minor in Economics from North Carolina State University.